Trump Administration Awards Contract to Shift Drug Manufacturing to the United States

“For far too long, we’ve relied on foreign manufacturing and supply chains for our most important medicines and active pharmaceutical ingredients while placing America’s health, safety, and national security at grave risk,” Director of the White House Office of Trade and Manufacturing Policy Peter Navarro said.